Author | Jeffrey Humphrey, MD | OncLive

Author | Jeffrey Humphrey, MD

Articles

Dr. Humphrey on Mogamulizumab for Cutaneous T-Cell Lymphoma

July 03, 2018

Jeffrey Humphrey, MD, president, Kyowa Hakko Kirin Pharma, Inc., discusses the benefits of mogamulizumab for the treatment of cutaneous T-cell lymphoma.

x